Goldman Sachs Group »

Fibrobiologics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $64k 13k 4.99

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial
Ethos Financial Group

View all funds holding Fibrobiologics